KGA 0941
Latest Information Update: 12 Dec 2006
At a glance
- Originator Kyorin Pharmaceutical
- Class
- Mechanism of Action Serotonin 3 receptor antagonists; Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 26 May 2001 No-Development-Reported for Gastrointestinal disorders in Japan (Unknown route)
- 11 Feb 1998 Preclinical development for Gastrointestinal disorders in Japan (Unknown route)